The generics are less flashy investments as compared to biotechnology companies. However, they also carry much less risk and offer steady growth to investors. Investments in small capitalization ...

Actavis (ACT) announced Monday that it will buy its pharmaceutical peer Allergan (AGN) in a $66 billion deal that appears to have finally thwarted efforts by Valeant Pharmaceuticals (VRX) to acquire ...

NEW YORK (AP) -- Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market. The ...

PARSIPPANY, N.J., April 1, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that the United States District Court for the District of New Jersey has ruled that Actavis' generic version ...

Irish pharmaceutical company Actavis will buy Allergan, the maker of Botox, for $219 per share in cash and stock, the company said in a press release. Actavis' CEO Brent Saunders will lead the company ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - This photo provided by Actavis shows the company's logo. Actavis PLC plans to buy Forest Laboratories Inc. in an ...

A definitive agreement has been reached in which New Jersey-based Actavis will acquire Ireland-based pharma company Warner Chilcott in an all-stock transaction valued at $8.5 billion, the companies ...

The soon-to-be owner of Irvine-based Allergan Inc. announced sweeping leadership changes that pass over many current executives including the Botox maker’s CEO. Irish pharmaceutical giant Actavis ...

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Actavis plc (NYSE: ACT) has taken over the #106 spot from Bank of New York Mellon Corp (NYSE: ...

If Actavis were allowed to discontinue sales of an older Alzheimer’s pill and steer patients toward a newer version in order to blunt generic competition, the move could cost Medicare Part D as much ...

PARSIPPANY, N.J., April 16, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today announced that it has re-launched Vestura™ (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of ...

NEW YORK Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market. The announcement ...